Publications by authors named "Alexander Gaiger"

25Publications

Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.

Clin Cancer Res 2014 Jun 2;20(11):2984-93. Epub 2014 Apr 2.

Authors' Affiliations: Departments of Biomedical Imaging and Image-guided Therapy, Internal Medicine I, Internal Medicine III, and Opthalmology and Optometry, and Institute of Pathology, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3355DOI Listing
June 2014

The caregivers' perspective on the end-of-life phase of glioblastoma patients.

J Neurooncol 2013 May 15;112(3):403-11. Epub 2013 Feb 15.

Department of Medicine I, Medical University of Vienna, Austria Comprehensive Cancer Center, Central Nervous System Tumors Unit (CCC-CNS), Währinger Gürtel 18-20, 1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-013-1069-7DOI Listing
May 2013

Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia.

Blood 2013 Feb 20;121(7):1175-83. Epub 2012 Nov 20.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-447359DOI Listing
February 2013

Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors.

J Neurooncol 2012 Sep 29;109(2):331-9. Epub 2012 May 29.

Department of Medicine I, Medical University of Vienna, Austria Comprehensive Cancer Center - Central Nervous System Tumours Unit (CCC-CNS), Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0897-1DOI Listing
September 2012

Prevalence and clinical impact of autoimmune diseases and chronic infections in malignant lymphomas at diagnosis.

Ann Hematol 2011 Aug 17;90(8):947-54. Epub 2011 Feb 17.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Comprehensive Cancer Center (CCC), Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://search.proquest.com/openview/f54226f88dd05fd9d38a6409
Web Search
http://link.springer.com/10.1007/s00277-011-1178-3
Publisher Site
http://dx.doi.org/10.1007/s00277-011-1178-3DOI Listing
August 2011

Nonpegylated liposomal doxorubicin is highly active in patients with B and T/NK cell lymphomas with cardiac comorbidity or higher age.

Ann Hematol 2010 Feb 28;89(2):163-9. Epub 2009 Jul 28.

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0796-5DOI Listing
February 2010

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

J Clin Oncol 2008 May;26(14):2252-7

Laboratory for Immunological and Molecular Cancer Research, Third Medical Department, Salzburg University Hospital, Muellner Hauptstrasse 48, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.5212DOI Listing
May 2008

Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.

Leuk Lymphoma 2007 Jun;48(6):1139-49

Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701385173DOI Listing
June 2007

Upregulation of retinoic acid receptor-beta by the epidermal growth factor-receptor inhibitor PD153035 is not mediated by blockade of ErbB pathways.

J Cell Physiol 2007 Jun;211(3):803-15

Department of Medicine I, Division of Oncology, Signaling Networks Program, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.20990DOI Listing
June 2007

An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.

Biochem Biophys Res Commun 2005 Apr;329(4):1253-9

Signaling Networks Program, Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2005.02.104DOI Listing
April 2005